If you have diabetes and you keep getting urinary tract infections, this is not a coincidence. It is not bad luck, and it is not simply a matter of not drinking enough water. If you’ve ever treated a UTI only to have it return weeks later, you’re not imagining it, there is a deeper biological reason behind this cycle. There is a direct, well-established biological relationship between diabetes and urinary tract infections, and understanding it could change how you manage both conditions.
UTIs are already the second most common bacterial infection seen in clinical practice. But in people with diabetes, the risk is dramatically higher, the infections tend to be more severe, and the complications are more serious. Research published in Diabetes Care found that women with diabetes are up to twice as likely to develop a UTI compared to women without the condition. For some subgroups, particularly older women with poorly controlled blood sugar, that risk is even higher.
So, what is diabetes actually doing to your urinary tract, and what can you do about it?
Let’s break down what’s happening inside your body.
High Blood Sugar Creates the Perfect Environment for Bacteria
This is the most fundamental mechanism, and it starts with glucose in your urine.
In a healthy person, the kidneys filter glucose back into the bloodstream before urine is produced, so urine contains little to no sugar. In people with poorly controlled diabetes, particularly when HbA1c is elevated, glucose spills into the urine because the kidneys can no longer reabsorb it all efficiently. This is called glycosuria.
Bacteria, particularly Escherichia coli, thrive on glucose. A sugar rich urinary environment is essentially a feeding ground, it accelerates bacterial growth, helps pathogens establish themselves on the bladder wall faster, and makes it significantly harder for your immune system to clear the infection. A study published in the European Journal of Clinical Microbiology and Infectious Diseases confirmed that glycosuria is independently associated with increased UTI risk, and that tighter glucose control substantially reduces this vulnerability.
The message here is simple but powerful: every percentage point improvement in your HbA1c reduces the biological conditions that allow UTIs to take hold.
Diabetes Weakens the Immune Response Where It Matters Most
Managing blood sugar is not just about glucose levels, it is about immune function. Chronically elevated blood sugar impairs the activity of neutrophils, which are the white blood cells your body sends first to fight bacterial infections. Research shows that in people with diabetes, neutrophil function is significantly blunted, they are slower to arrive at the site of infection, less effective at engulfing and destroying bacteria, and less capable of producing the chemical signals that coordinate your broader immune response.
In practical terms, this means your body is responding, just not fast enough. By the time your immune system mounts a meaningful defense against a UTI, the bacteria may already have established a much stronger foothold than it would in someone without diabetes. This is one of the reasons UTIs in people with diabetes are more likely to progress to kidney infections, a condition called pyelonephritis, which can be serious and, in some cases, life-threatening if not caught early.
According to research in Clinical Infectious Diseases, people with diabetes are significantly more likely than those without the condition to experience complicated UTIs, including upper urinary tract involvement, bacteraemia, and hospitalization.
Diabetic Neuropathy and Bladder Dysfunction
Here is a complication that is frequently overlooked in the context of UTIs, diabetic bladder dysfunction, also called diabetic cystopathy.
Long standing diabetes damages nerves throughout the body, and the bladder is no exception. The nerves responsible for signaling when your bladder is full, and for coordinating the muscle contractions that empty it completely, can become impaired over time. The result is a bladder that does not empty fully, a condition called incomplete voiding or urinary retention.
Residual urine sitting in the bladder is a breeding ground for bacteria. Rather than being flushed out with each urination, pathogens have time to multiply, adhere to the bladder wall, and establish infection. A study published in Neurourology and Urodynamics found that people with diabetes and evidence of bladder dysfunction had significantly higher rates of recurrent UTIs compared to those with normal bladder emptying.
If your bladder never feels completely empty, that’s not something to ignore, it may be directly driving your recurrent infections. This is worth raising with your healthcare provider.
Women With Diabetes Face Compounding Risks
Women already have a shorter urethra than men, which gives bacteria a shorter route to the bladder. But in women with diabetes, additional factors compound this anatomical vulnerability.
High glucose levels in vaginal secretions alter the vaginal microbiome, reducing populations of protective Lactobacillus bacteria and creating conditions in which pathogenic organisms like E. coli and Candida thrive. This disruption to vaginal flora does not just increase the risk of thrush, it directly increases the likelihood of urinary pathogens colonising the perineum and ascending into the urethra.
For women with diabetes who are also perimenopausal or postmenopausal, the picture becomes even more complex. Oestrogen decline compounds the Lactobacillus loss, thins the urethral mucosa, and raises vaginal pH, layering hormonal vulnerability on top of metabolic vulnerability. Research published in Menopause found that postmenopausal women with diabetes had some of the highest recorded rates of recurrent UTIs of any demographic studied.
SGLT2 Inhibitors, An Important Medication Consideration
If you are taking an SGLT2 inhibitor, empagliflozin, dapagliflozin, or canagliflozin, this is directly relevant to your UTI risk and something your pharmacist or doctor should have discussed with you.
SGLT2 inhibitors work by blocking glucose reabsorption in the kidneys, deliberately causing excess glucose to be excreted in the urine. This is how they lower blood sugar, but it also means they intentionally create glycosuria, the same sugar-rich urinary environment that promotes bacterial growth. Clinical trial data and post marketing surveillance have consistently shown that SGLT2 inhibitors are associated with a modestly increased risk of urinary tract infections, particularly genital mycotic infections in women.
This does not mean the medication is a problem, it means the context matters. SGLT2 inhibitors have significant cardiovascular and renal protective benefits that far outweigh the UTI risk for most patients. But if you are experiencing recurrent infections, your prescriber needs to know so your plan can be adjusted safely.
Reducing Your Risk, Evidence Based Strategies That Actually Work
The most important step is glycaemic control. Managing blood sugar as tightly as your individual targets allow remains the single most impactful thing you can do to reduce UTI frequency. Better glycaemic control reduces glycosuria, partially restores immune function, and slows the progression of diabetic neuropathy affecting bladder function. When you improve your HbA1c, you are not just managing diabetes, you are actively removing the conditions that allow infections to start.
Hydration is simple but genuinely effective. Aiming for pale yellow urine throughout the day keeps bacteria flushed through the urinary tract before they have a chance to adhere and multiply. For people with diabetes who may experience increased thirst and urination, consistent fluid intake is especially important, dehydration concentrates glucose in the urine further, worsening the very environment that promotes bacterial growth.
D-mannose deserves a specific mention here. This naturally occurring sugar works by binding to the fimbriae, the adhesive appendages E. coli uses to stick to the bladder wall, coating the bacteria so it is flushed out in urine rather than establishing infection. A clinical trial published in the World Journal of Urology found D-mannose powder to be as effective as low dose antibiotic prophylaxis for preventing recurrent UTIs, with significantly fewer side effects. While promising, it works best as part of a broader prevention strategy rather than a standalone fix.
Probiotic support is worth considering alongside D-mannose. Specific Lactobacillus strains, particularly Lactobacillus rhamnosus and Lactobacillus reuteri, have shown promising results in clinical research for restoring vaginal flora and reducing UTI recurrence in women prone to repeat infections. In people with diabetes, where high glucose levels already disrupt the vaginal microbiome, daily probiotic supplementation may help restore some of the protective bacterial balance that diabetes erodes.
Bladder habits matter more than most people realize. Urinating regularly, every three to four hours rather than holding, reduces the time bacteria have to multiply in residual urine. If you have had diabetes for several years and notice incomplete bladder emptying or a weakened urine stream, raise this with your doctor. Diabetic bladder dysfunction is a real and underdiagnosed condition, and addressing it directly can break the cycle of recurrent infections more effectively than antibiotics alone.
It’s also worth noting that repeated antibiotic use can increase the risk of resistance, making future infections harder to treat, which is why prevention matters even more in diabetes.
For women with diabetes who are also perimenopausal or postmenopausal, topical oestrogen (estrogen) therapy is one of the most underused and evidence-backed interventions available. Applied directly as a cream, pessary, or vaginal ring, it restores the urethral and vaginal tissue that oestrogen loss degrades, rebuilds Lactobacillus populations, and has been shown in multiple clinical studies to substantially reduce UTI recurrence. Systemic absorption is minimal, making it safe for most women. If recurrent UTIs worsened around the time of your menopause transition and you have not yet had this conversation with your GP, it is one worth initiating.
Finally, if you are on an SGLT2 inhibitor and experiencing recurrent UTIs, tell your prescriber. Do not stop the medication without guidance, these drugs carry significant cardiovascular and renal benefits, but your clinical team may be able to adjust your management plan, increase monitoring frequency, or add prophylactic measures that reduce infection risk while keeping you on a medication that is doing important work elsewhere.
When to See Your Doctor Without Delay
In people with diabetes, UTI symptoms that might seem straightforward can progress to serious complications faster than they would in someone without the condition. Seek medical attention promptly if you develop fever, back or flank pain, nausea or vomiting alongside UTI symptoms, these can indicate the infection has reached the kidneys and requires urgent assessment and treatment.
If you are having two or more UTIs within six months, ask your doctor for a urine culture with sensitivity testing rather than empirical antibiotic treatment. In people with diabetes especially, knowing the specific bacteria and its antibiotic sensitivities is important, both to ensure effective treatment and to monitor for resistant strains.
The Bottom Line
Diabetes and UTIs are linked at a biological level, through blood sugar, immune function, nerve damage, and the vaginal microbiome. Understanding that connection puts you in a far stronger position to manage both. Better glucose control, appropriate supplementation, hormonal support where relevant, and prompt medical attention when infections do occur are all part of a strategy that goes well beyond simply waiting for the next prescription.
When you address the root causes, not just the symptoms, you break the cycle not just temporarily, but long term.
Your diabetes team and your pharmacist are both valuable resources here. Use them.
FAQs
Q1. Does diabetes directly cause UTIs?
Diabetes does not directly cause UTIs, but it creates several biological conditions that make them significantly more likely. High glucose in the urine feeds bacteria, impaired immune function reduces your ability to fight infection, and nerve damage can prevent the bladder from emptying fully, all of which give urinary pathogens a considerable advantage.
Q2. Why do UTIs seem more severe when you have diabetes?
Because diabetes blunts the neutrophil response, the immune cells your body dispatches first to fight bacterial infection. By the time a meaningful immune response is mounted, the infection may already be more established. This is why UTIs in people with diabetes are more likely to progress to kidney infections, and why prompt treatment matters more than it might in someone without the condition.
Q3. Can better blood sugar control actually reduce UTI frequency?
Yes, and this is one of the most evidence-backed points in this article. Tighter glycaemic control reduces glucose spilling into the urine, partially restores neutrophil function, and slows the nerve damage that contributes to incomplete bladder emptying. Bringing your HbA1c down is one of the most direct things you can do to reduce your UTI risk alongside conventional prevention strategies.
Q4. Do SGLT2 inhibitors like empagliflozin increase UTI risk?
They are associated with a modestly increased risk, particularly of genital mycotic infections in women, because they work by deliberately excreting glucose into the urine. However, the cardiovascular and renal benefits of SGLT2 inhibitors are significant and well established. Do not stop this medication without speaking to your prescriber, but do inform them if you are experiencing recurrent UTIs so your management plan can be reviewed.
Q5. Is D-mannose safe to take if you have diabetes?
D-mannose is generally considered safe, and unlike cranberry supplements, it does not contain significant amounts of sugar that would affect blood glucose. It works by binding to E. coli in the urinary tract rather than being metabolized in the conventional sense. That said, always discuss any new supplement with your pharmacist or doctor before starting, particularly if you are on multiple medications for diabetes management.
Q6. What is diabetic bladder dysfunction and how does it cause UTIs?
Diabetic bladder dysfunction, also called diabetic cystopathy, occurs when long-standing diabetes damages the nerves controlling bladder function. This can result in incomplete bladder emptying, meaning residual urine sits in the bladder between visits to the toilet. That stagnant urine creates the ideal environment for bacteria to multiply and establish infection. It is underdiagnosed and worth raising with your healthcare provider if you notice a weak urine stream or a persistent sense of incomplete emptying.
Q7. Are women with diabetes at higher risk than men?
Yes, Women already have a shorter urethra than men, giving bacteria a shorter path to the bladder. In women with diabetes, this anatomical vulnerability is compounded by glucose-driven disruption to the vaginal microbiome and, in those who are perimenopausal or postmenopausal, by oestrogen-related changes to urethral and vaginal tissue. Postmenopausal women with diabetes consistently show some of the highest rates of recurrent UTIs of any demographic in clinical research.
Q8. Can topical oestrogen help reduce UTIs if I have diabetes and am postmenopausal?
It can, and the evidence is strong. Topical oestrogen applied locally as a cream, pessary, or vaginal ring restores the tissue integrity of the urethra and vaginal lining, rebuilds Lactobacillus populations, and has been shown in multiple studies to significantly reduce UTI recurrence in postmenopausal women. Systemic absorption is minimal, making it appropriate for most women. If your UTIs worsened around the time of your menopause transition, this is a conversation worth having directly with your doctor.
Q9. When should someone with diabetes go to their doctor for a UTI rather than waiting?
Always sooner rather than later. In people with diabetes, infections can escalate more quickly due to impaired immunity. Seek same-day medical attention if you have a fever, back or flank pain, nausea, or vomiting alongside urinary symptoms these suggest the infection may have reached the kidneys. Do not wait for symptoms to worsen. If you are experiencing two or more UTIs within six months, ask specifically for a urine culture and sensitivity test rather than a repeat empirical prescription.
Call to Action
If you have diabetes and UTIs keep disrupting your life, the answer is rarely just another antibiotic. At PharmaHealths, we translate complex clinical evidence into clear, actionable health information, so you can understand what is happening in your body and have more productive conversations with your healthcare team. Explore more evidence-based articles on diabetes, women’s health, and infection at pharmahealths.com.
Disclaimer
This article is intended for informational and educational purposes only and does not constitute medical advice. The content is written from a pharmacist’s perspective to support general health awareness. If you have diabetes and are experiencing recurrent urinary tract infections, please consult your doctor or a qualified healthcare professional for personalized assessment and treatment. Do not stop, adjust, or delay any prescribed medication, including SGLT2 inhibitors or other diabetes medications, based on information contained in this article.
References
• Geerlings SE et al. Urinary tract infections in patients with diabetes mellitus. Diabetes Care. 2000.
• Nitzan O et al. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes, Metabolic Syndrome and Obesity. 2015.
• Muller LM et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical Infectious Diseases. 2005.
• Boyko EJ et al. Probability of urinary tract infection following catheterisation, risk factors in diabetic and non-diabetic women. American Journal of Medicine. 2005.
• Kelleher JP et al. Diabetic cystopathy and incomplete bladder emptying as a risk factor for recurrent UTI. Neurourology and Urodynamics. 2006.
• Eells SJ et al. Recurrent urinary tract infections in postmenopausal women with diabetes. Menopause. 2014.
• Zinman B et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine. 2015.
• Johnsson KM et al. Urinary tract infections and genital mycotic infections associated with dapagliflozin. Diabetes, Obesity and Metabolism. 2013.
• Pietrzak B et al. D-mannose vs antibiotic prophylaxis for recurrent UTI prevention. World Journal of Urology. 2022.
• Stapleton AE. The vaginal microbiota and urinary tract infection. Microbiology Spectrum. 2016.
• Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New England Journal of Medicine. 1993.